|
Kimberly
It says "more effective" preventative measures ie, many treatments do not cross the blood-brain barrier to get into the brain and fight micrometastases there becoming full-blown mets. One exception is lapatinib--we all hope GlaxoSmithKline will request FDA approval for it in late 2006 or early 2007. When it will become available for use is anyone's guess--we all hope soon!
Lani
|